Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportIn vitro and In vivo Oncology

9mTc-HYNIC-LHRH analogue as a novel prostate cancer imaging agent

Lucia Alfaya, Marcos Tassano, Ximena Camacho, Mirel Cabrera, Ana Reyes, Andrea Paolino, Maria Garcia, Marcelo Ferandez, Eduardo Savio, Pablo Duarte, Pablo Cabral and Juan Gambini
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 4059;
Lucia Alfaya
1CUDIM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcos Tassano
2Centro de Investigaciones Nucleares, Facultad de Ciencias, UdelaR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ximena Camacho
3Facultad de Ciencias, Universidad de la República (UDELAR)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mirel Cabrera
2Centro de Investigaciones Nucleares, Facultad de Ciencias, UdelaR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Reyes
1CUDIM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Paolino
1CUDIM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Garcia
2Centro de Investigaciones Nucleares, Facultad de Ciencias, UdelaR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcelo Ferandez
2Centro de Investigaciones Nucleares, Facultad de Ciencias, UdelaR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eduardo Savio
1CUDIM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pablo Duarte
1CUDIM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pablo Cabral
2Centro de Investigaciones Nucleares, Facultad de Ciencias, UdelaR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Gambini
4CUDIM // Centro de Medicina Nuclear e Imagenología Molecular, Hospital de Clínicas, UdelaR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 63 no. supplement 2 4059

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 8, 2022.

Copyright & Usage 
© 2022

Author Information

  1. Lucia Alfaya1,
  2. Marcos Tassano2,
  3. Ximena Camacho3,
  4. Mirel Cabrera2,
  5. Ana Reyes1,
  6. Andrea Paolino1,
  7. Maria Garcia2,
  8. Marcelo Ferandez2,
  9. Eduardo Savio1,
  10. Pablo Duarte1,
  11. Pablo Cabral2 and
  12. Juan Gambini4
  1. 1CUDIM
  2. 2Centro de Investigaciones Nucleares, Facultad de Ciencias, UdelaR
  3. 3Facultad de Ciencias, Universidad de la República (UDELAR)
  4. 4CUDIM // Centro de Medicina Nuclear e Imagenología Molecular, Hospital de Clínicas, UdelaR

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: July 2022 to April 2025

AbstractFullPdf
Jul 2022100
Aug 20221000
Sep 20221200
Oct 2022900
Nov 20221100
Dec 20221900
Jan 20232100
Feb 20231000
Mar 20232600
Apr 2023700
May 20231800
Jun 20231100
Jul 2023800
Aug 2023500
Sep 20231100
Oct 2023900
Nov 2023600
Dec 20231100
Jan 20241000
Feb 2024600
Mar 2024600
Apr 20243500
May 20241000
Jun 20242500
Jul 202411100
Aug 202410000
Sep 20243600
Oct 20241000
Nov 20242000
Dec 20242300
Jan 2025900
Feb 20253700
Mar 2025700
Apr 20251100
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
9mTc-HYNIC-LHRH analogue as a novel prostate cancer imaging agent
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
9mTc-HYNIC-LHRH analogue as a novel prostate cancer imaging agent
Lucia Alfaya, Marcos Tassano, Ximena Camacho, Mirel Cabrera, Ana Reyes, Andrea Paolino, Maria Garcia, Marcelo Ferandez, Eduardo Savio, Pablo Duarte, Pablo Cabral, Juan Gambini
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 4059;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
9mTc-HYNIC-LHRH analogue as a novel prostate cancer imaging agent
Lucia Alfaya, Marcos Tassano, Ximena Camacho, Mirel Cabrera, Ana Reyes, Andrea Paolino, Maria Garcia, Marcelo Ferandez, Eduardo Savio, Pablo Duarte, Pablo Cabral, Juan Gambini
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 4059;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Biodistribution of 111In-DPI-4452 and 111In-DPI-4501, two novel Carbonic Anhydrase IX-targeting radiopeptides, in xenografted mouse and healthy dog
  • New 64Cu-labeled CXCR4-targeting ligands for theranostic applications
  • Radioimmunotherapy using Anti-CD20 Antibody, 177Lu-Ofatumumab, Cures Lymphoma in a Preclinical Model
Show more In vitro and In vivo Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire